Madrigal Pharmaceuticals, Inc. - stock earnings
MDGL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -112.2 million USD | ? USD |
| 2023Q3 | -98.7 million USD | ? USD |
| 2023Q2 | -85.8 million USD | ? USD |
| 2023Q1 | -77.8 million USD | ? USD |
| 2022Q4 | -87.6 million USD | ? USD |
| 2022Q3 | -82.7 million USD | ? USD |
| 2022Q2 | -71.5 million USD | ? USD |
| 2022Q1 | -57.6 million USD | ? USD |
| 2021Q4 | -64.5 million USD | 37 USD |
| 2021Q3 | -63.1 million USD | 8287 USD |
| 2021Q2 | -61.7 million USD | 10110 USD |
| 2021Q1 | -52.5 million USD | 273000 USD |
| 2020Q4 | -59.1 million USD | ? USD |
| 2020Q3 | -58.0 million USD | 0 USD |
| 2020Q2 | -49.0 million USD | 100000 USD |
| 2020Q1 | -36.1 million USD | ? USD |
| 2019Q4 | -27.7 million USD | ? USD |
| 2019Q3 | -21.4 million USD | ? USD |
| 2019Q2 | -19.7 million USD | ? USD |
| 2019Q1 | -15.1 million USD | ? USD |
| 2018Q4 | -11.5 million USD | ? USD |
| 2018Q3 | -8.5 million USD | ? USD |
| 2018Q2 | -6.5 million USD | 200000 USD |
| 2018Q1 | -6.4 million USD | ? USD |
| 2017Q4 | -8.4 million USD | 250000 USD |
| 2017Q3 | -8.4 million USD | 100000 USD |
| 2017Q2 | -8.3 million USD | ? USD |
| 2017Q1 | -6.0 million USD | ? USD |
| 2016Q4 | -7.7 million USD | ? USD |
| 2016Q3 | -14.0 million USD | ? USD |
| 2016Q2 | -3.4 million USD | ? USD |
| 2016Q1 | -6.5 million USD | ? USD |
| 2015Q4 | -10.5 million USD | ? USD |
| 2015Q3 | -17.6 million USD | ? USD |
| 2015Q2 | -19.8 million USD | ? USD |
| 2015Q1 | -20.7 million USD | ? USD |
| 2014Q4 | -20.4 million USD | ? USD |
| 2014Q3 | -20.0 million USD | ? USD |
| 2014Q2 | -22.3 million USD | ? USD |
| 2014Q1 | -23.6 million USD | ? USD |
| 2013Q4 | -24.2 million USD | ? USD |
| 2013Q3 | -22.5 million USD | ? USD |
| 2013Q2 | -22.8 million USD | ? USD |
| 2013Q1 | -20.7 million USD | ? USD |
| 2012Q4 | -18.1 million USD | 7.4 million USD |
| 2012Q3 | -15.0 million USD | ? USD |
| 2012Q2 | -14.6 million USD | ? USD |
| 2012Q1 | -15.1 million USD | 147000 USD |
| 2011Q4 | -10.7 million USD | 3.4 million USD |
| 2011Q3 | -12.7 million USD | 1.7 million USD |
| 2011Q2 | -12.5 million USD | 1.4 million USD |
| 2011Q1 | -11.4 million USD | 1.1 million USD |
| 2010Q4 | -8.8 million USD | 4.0 million USD |
| 2010Q3 | -10.3 million USD | 3.4 million USD |
| 2010Q2 | -9.1 million USD | 3.4 million USD |
| 2010Q1 | -9.3 million USD | 4.0 million USD |
| 2009Q4 | -7.0 million USD | 4.7 million USD |
| 2009Q3 | 118.1 million USD | 130.4 million USD |
| 2009Q2 | -8.5 million USD | 4.7 million USD |
| 2009Q1 | -23.5 million USD | 4.5 million USD |
| 2008Q4 | -26.0 million USD | 636000 USD |
| 2008Q3 | -26.3 million USD | 1.3 million USD |
| 2008Q2 | -22.7 million USD | 1.3 million USD |
| 2008Q1 | -17.7 million USD | 1.3 million USD |
| 2007Q4 | -15.5 million USD | 743000 USD |
| 2007Q3 | -14.9 million USD | ? USD |
| 2007Q2 | -16.7 million USD | ? USD |
| 2007Q1 | -16.4 million USD | ? USD |
| 2006Q4 | -12.5 million USD | ? USD |
| 2006Q3 | -14.9 million USD | ? USD |
| 2006Q2 | -14.9 million USD | ? USD |
| 2006Q1 | -14.9 million USD | ? USD |
| 2005Q4 | -15.5 million USD | ? USD |
| 2005Q3 | -26.7 million USD | ? USD |
| 2005Q2 | -26.7 million USD | ? USD |
| 2005Q1 | -17.9 million USD | ? USD |
| 2004Q1 | -8.8 million USD | 173000 USD |
MDGL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -373.6 million USD | ? USD |
| 2022 | -299.3 million USD | ? USD |
| 2021 | -241.1 million USD | 37318 USD |
| 2020 | -197.4 million USD | 21864 USD |
| 2019 | -72.8 million USD | ? USD |
| 2018 | -32.8 million USD | 200000 USD |
| 2017 | -31.2 million USD | 350000 USD |
| 2016 | -26.4 million USD | ? USD |
| 2015 | -68.7 million USD | ? USD |
| 2014 | -86.2 million USD | ? USD |
| 2013 | -90.2 million USD | ? USD |
| 2012 | -62.8 million USD | 147000 USD |
| 2011 | -47.4 million USD | 7.6 million USD |
| 2010 | -37.5 million USD | 14.8 million USD |
| 2009 | 79.1 million USD | 144.2 million USD |
| 2008 | -92.6 million USD | 2.6 million USD |
| 2007 | -63.5 million USD | 743000 USD |
| 2006 | -57.3 million USD | ? USD |
| 2005 | -68.9 million USD | ? USD |
| 2004 | -45.9 million USD | 173000 USD |
| 2003 | -27.9 million USD | 1.3 million USD |
| 2002 | -36.2 million USD | ? USD |
| 2001 | -381000 USD | ? USD |
MDGL
Price: $229.84
52 week price:
Earnings Per Share: -19.99 USD
P/E Ratio: -8.90
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 132314
Ebitda: -8.4 millionMarket Capitalization: 5.0 billion